Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
This approach involves comprehensive molecular simulations of the catalytic and allosteric binding pockets and ensemble virtual screening that accounts for their conformational flexibility. In the case of designing modulators, the structural adjustments caused by reaction intermediates are considered to improve activity and selectivity.
Several key aspects differentiate our library:
partner
Reaxense
upacc
Q99956
UPID:
DUS9_HUMAN
Alternative names:
Mitogen-activated protein kinase phosphatase 4
Alternative UPACC:
Q99956; D3DWU5
Background:
Dual specificity protein phosphatase 9 (DUSP9), also known as Mitogen-activated protein kinase phosphatase 4, plays a crucial role in cellular processes by inactivating MAP kinases, specifically targeting the ERK family. This protein's ability to regulate MAP kinases positions it as a key modulator in cell signaling pathways, influencing cell growth, differentiation, and response to external stress.
Therapeutic significance:
Understanding the role of Dual specificity protein phosphatase 9 could open doors to potential therapeutic strategies. Its pivotal function in MAP kinase signaling pathways suggests its involvement in cellular processes that are often dysregulated in diseases. Targeting DUSP9 could provide a novel approach to modulate these pathways in disease contexts.